Q: Can you please provide your opinion on a long term hold of Hamilton Thorne ($HTL.v) from this level? Currently the company includes the original IVF equipment business, toxicity testing business, and a European full service distribution business.
The company has telegraphed its intention to continue growth by the following:
1. Making meaningful acquisitions with active discussions underway;
2. Organic growth by expanding into new geographies and expanding the breadth of product and service offerings from both internal R&D and adding new 3rd party suppliers on the global platform; and
3. Cross selling between all of the integrated businesses.
It is also at the ~$100M market cap (fully diluted) where both new institutional and retail investors alike will start to take notice.
TIA,
Meredith
The company has telegraphed its intention to continue growth by the following:
1. Making meaningful acquisitions with active discussions underway;
2. Organic growth by expanding into new geographies and expanding the breadth of product and service offerings from both internal R&D and adding new 3rd party suppliers on the global platform; and
3. Cross selling between all of the integrated businesses.
It is also at the ~$100M market cap (fully diluted) where both new institutional and retail investors alike will start to take notice.
TIA,
Meredith